Affordability Check
How to afford PADCEV EJFV
Generic name: ENFORTUMAB VEDOTIN
Pick how you're covered. We'll show you the cheapest legitimate way to get PADCEV EJFV — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About PADCEV EJFV and its cost
What is this medication? Padcev, which has the generic name enfortumab vedotin-ejfv, is a prescription medication used to treat adults with advanced or metastatic urothelial cancer, which is a type of cancer that affects the bladder or urinary tract. It is classified as an antibody-drug conjugate, a targeted therapy designed to seek out and destroy cancer cells. This drug works by identifying a specific protein called Nectin-4 that is often found on the surface of bladder cancer cells, allowing it to deliver a potent chemotherapy agent directly into the tumor while minimizing damage to healthy cells.
This medication is generally prescribed for patients whose cancer has worsened after receiving platinum-based chemotherapy and immunotherapy treatments. It may also be used as an initial treatment option when combined with another immunotherapy drug called pembrolizumab for patients with advanced disease. Because it is a specialized treatment, Padcev is administered through an intravenous infusion by healthcare professionals in a hospital or clinic setting.
PADCEV EJFV is made by Astellas. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford PADCEV EJFV?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for PADCEV EJFV?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Astellas has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover PADCEV EJFV?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Cancer?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about PADCEV EJFV
Full PADCEV EJFV drug page
FDA label, prior authorization rules, full indications list
More options for Cancer
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3